Paradigm Biopharmaceuticals Ltd.ASX: PAR

Paradigm Receives $7.36m R&D Tax Incentive Refund

Feb 7, 2024 at 3:35 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment